Zoledronic acid as adjuvant therapy in neovascular age-related macular degeneration: a randomised controlled pilot study

Zoledronic acid as adjuvant therapy in neovascular age-related macular degeneration: a randomised controlled pilot study

Aims To assess the feasibility of a study protocol for a randomised controlled trial of zoledronic acid (ZA) as adjuvant therapy for neovascular age-related macular degeneration (nAMD).Methods In this 1-year, randomised, double-blinded, placebo-controlled pilot study, nAMD patients were allocated 1:...

Full description

Saved in:
Bibliographic Details
Main Authors: Øystein Kalsnes Jørstad, Morten Carstens Moe, Morten Wang Fagerland, Yngvil Solheim Husum, Erik Fink Eriksen
Format: Article
Language:English
Published: BMJ Publishing Group 2024-12-01
Series:BMJ Open Ophthalmology
Online Access:https://bmjophth.bmj.com/content/9/1/e001964.full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items